Sign in
Back
Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017
Journal article   Peer reviewed

Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017

Anshul Saxena, Muni Rubens, Joseph A Salami, Peter McGranaghan, Chintan Bhatt, Sankalp Das, Venkataraghavan Ramamoorthy and Emir Veledar
Circulation, Vol.141
2020
DOI: https://doi.org/10.1161/circ.141.suppl_1.p340

Abstract

Background: In August 2019, FDA approved TAVR for low-risk patients, a paradigm shift in the field of Cardiology. This approval will pave the way for TAVR to rapidly become mainstream, and it will ...
url
https://lens.org/020-680-704-170-559View
url
https://works.bepress.com/sankalp-das/62/View
url
https://www.ahajournals.org/doi/abs/10.1161/circ.141.suppl_1.P340View
url
https://scholarlycommons.baptisthealth.net/se-all-publications/3515/View

Metrics

4 Record Views

Details